Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
Clinical trial NCT06087068 · RECRUITING
Trial details
- NCT number
- NCT06087068
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2026-07-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.